Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05786456 · ClinicalTrials.gov registry record · NA

e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

A NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT05786456: Active NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8, sponsored by City of Hope Medical Center.

NCT05786456 is a NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8 that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 23 participants, below the 403-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05786456, a NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies how well an electronic (e)-health intervention (day-by-day) woks in managing fears or worries about cancer growing, spreading, or getting worse (progression) in patients with stage III or IV gynecologic cancer. Fear and worries about cancer progression or recurrence (coming back) are common concerns. This may contribute to concerns related to illness, worries, and uncertainty about the future. Day by Day is adapted from a program called "Conquer Fear" which was shown to benefit patients with early-stage cancer. Day-by-day intervention may help refocus patient thoughts and help patients learn skills to manage anxiety and fears.

Primary Outcome

Defined by attendance, attrition, and skills practice adherence. Website acceptability is based on the System Usability Scale, log-in activity, activity completion rate, and most frequently visited site content.

Conditions Studied

Malignant Female Reproductive System Neoplasm Stage III Ovarian Cancer AJCC v8 Stage IV Ovarian Cancer AJCC v8 Stage III Vulvar Cancer AJCC v8 Stage IV Cervical Cancer AJCC v8 Stage III Uterine Corpus Cancer AJCC v8 Stage III Cervical Cancer AJCC v8 Stage III Vaginal Cancer AJCC v8 Stage IV Uterine Corpus Cancer AJCC v8 Stage IV Vaginal Cancer AJCC v8

Interventions

  • OTHER Questionnaire Administration
  • OTHER Media Intervention
  • PROCEDURE Discussion
  • OTHER Informational Intervention
  • BEHAVIORAL Telephone-Based Intervention

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2024-07-19
Est. Completion 2026-12-15
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT05786456 still lists

NCT05786456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 403-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (94% lower).

The record links to 10 conditions, with Malignant Female Reproductive System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT05786456 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05786456 about?

NCT05786456 is a clinical study titled "e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study". This clinical trial studies how well an electronic (e)-health intervention (day-by-day) woks in managing fears or worries about cancer growing, spreading, or getting worse (progression) in patients with stage III or IV gynecologic cancer. Fear and worries about cancer progression or recurrence (comi...

What is the current status of trial NCT05786456?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2024-07-19. Estimated completion is 2026-12-15.

What conditions does trial NCT05786456 study?

This clinical trial studies the following conditions: Malignant Female Reproductive System Neoplasm, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8.

What interventions are being tested in trial NCT05786456?

The interventions under investigation include: Questionnaire Administration (OTHER), Media Intervention (OTHER), Discussion (PROCEDURE), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05786456?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05786456 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Female Reproductive System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05786456's enrollment target sits among peer trials

23 18th of 18 higher than 1 of 18 other Malignant Female Reproductive System Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Female Reproductive System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05786456, the US trial registry maintained by the National Library of Medicine. NCT05786456 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.